p73, miR106b, miR34a, and Itch in chronic lymphocytic leukemia.
Rivetti di Val Cervo
Pia
P
Tucci
Paola
P
Majid
Aneela
A
Lena
Anna Maria
AM
Agostini
Massimiliano
M
Bernardini
Sergio
S
Candi
Eleonora
E
Cohen
Gerry
G
Nicotera
Pierluigi
P
Dyer
Martin J S
MJ
Melino
Gerry
G
D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000502:physiology; D020169:Caspases / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000502:physiology*; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D035683:MicroRNAs / Q000502:physiology*; D009363:Neoplasm Proteins / Q000502:physiology*; D009687:Nuclear Proteins / Q000502:physiology*; D012097:Repressor Proteins / Q000378:metabolism*; D000072160:Tumor Protein p73; D025521:Tumor Suppressor Proteins / Q000502:physiology*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*
D000970:Antineoplastic Agents; D004268:DNA-Binding Proteins; D056572:Histone Deacetylase Inhibitors; C542541:MIRN106 microRNA, human; C522425:MIRN34 microRNA, human; D035683:MicroRNAs; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D012097:Repressor Proteins; C000606460:TP73 protein, human; D000072160:Tumor Protein p73; D025521:Tumor Suppressor Proteins; C432966:ITCH protein, human; D044767:Ubiquitin-Protein Ligases; D020169:Caspases